Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs

Oral Miltefosine for Indian Visceral Leishmaniasis

Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine · 2002 · 774 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

Shyam Sundar, Deepak K. More, Manoj Kumar Singh et al. · Clinical Infectious Diseases · 2000 · 651 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains of<i>Leishmania donovani</i>

Rosalía Lira, Shyam Sundar, Anand Makharia et al. · The Journal of Infectious Diseases · 1999 · 367 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

Ramtin Hadighi, Mehdi Mohebali, Patrick Boucher et al. · PLoS Medicine · 2006 · 298 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs

Karin Seifert, Simon L. Croft · Antimicrobial Agents and Chemotherapy · 2005 · 205 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15